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SUMMARY 
Objective: To report on the proportions of restrictive, 
obstructive and combined types of respiratory diseases 
in patients referred to respiratory units at the Korle Bu 
Teaching Hospital.   
Method: This was a retrospective study of lung 
function test (LFT) data on patients who were referred 
from clinics both in and outside KBTH.  A spirometer 
was used to assess various lung volume parameters. 
Results: One quarter of total subjects (25.5%) had 
obstructive, 14.8% restrictive and 11.7% exhibited 
combined forms of respiratory disease. The rest 
showed none of the above conditions and were 
classified as normal.  We also found differences in 
proportions of the disorders for subjects in different 
age and weight categories. Whereas obstructive 
respiratory disease occurred more in obese patients, 
and patients who were 35 years and above, restrictive 
and combined respiratory diseases occurred more in 
underweight patients, and patients below age 35 years. 
The respiratory diseases suggested in our study were 
found not to be sex-dependent. 
Conclusion: Our study indicates that obstructive lung 
disease was the most predominant respiratory lung 
ailment among patients referred to the respiratory units 
of Korle Bu Teaching Hospital.  
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INTRODUCTION 
Lung function tests, using spirometric techniques, are 
particularly effective in diagnosing the type and the 
severity of respiratory diseases in hospitals.
1,2
The two 
broad types usually diagnosed are restrictive and 
obstructive respiratory diseases. Besides these, there 
are cases comprising a combination of both types. 
These tests are also able to differentiate reversible 
obstructive disease (e.g. asthma) from irreversible or 
chronic obstructive pulmonary disease (e.g. 




Restrictive Respiratory Disease refers to the condition 
in which lung compliance is impaired. The lung’s 
characteristic property of compliance is a measure of 
its distensibility, which normally facilitates the 
expansion and contraction of lung space. The lungs 
tend to stiffen and cannot expand normally thereby 
causing reductions in lung volumes. Restrictive 
respiratory diseases
4,5
, broadly defined, include 
Sarcoidosis, Tuberculosis, Pnuemonectomy, 
Pneumonia, fibrosis,scoliosis, kyphosis,  ankylosing 
spondylitis, pleural effusion,  pregnancy, gross obesity, 




Obstructive Respiratory Disease refers to a condition 
of constricted airways, with increased airway 
resistance. The patient inspires normally but finds 
difficulty in expiration.
6
 Flow through the tubular 
passageways of the lung can be reduced due to 
bronchial smooth muscle contraction as is the case in 
asthma, narrowing of the airways due to inflammation 
and swelling of bronchial mucosa and the hypertrophy 
and hyperplasia of bronchial glands as is the case in 
bronchitis, material inside the bronchial passageways 
physically obstructing the flow of air as is the case in 
excessive mucus plugging, and inhalation of foreign 
objects or the presence of pushing and invasive tumors 
.   
Other causes include destruction of lung tissue with the 
loss of elasticity and hence the loss of the external 
support of the airways as is the case in emphysema, 
and external compression of the airways by tumors and 
trauma. Obstructive respiratory diseases may be 
reversible
6,7





Measurements in LFT’s: The following measurements 
are routinely taken during lung function tests:
2,4
  
VC (vital capacity) 
FVC (forced vital capacity) 
FEV1 (forced expiratory volume in one second) 
FEF25% - 75% (Forced Expiratory Flow) 
PEF (Peak Expiratory Flow) 
 
  




It is common in healthy individuals to be able to expel 
75% - 80 % of their vital capacity in the first second of 
the FVC test. Hence, FEV1 is a pulmonary function 
value that is highly diagnostic of obstructive disease, 
i.e. if an individual's FEV1 is low compared to the 
predicted FEV1 in the normal population, the 
individual may have an obstructive lung disease. FEV1 
is also expressed as a ratio or a percentage of the FVC 
and is written as %FEV1 or as FEV1/FVC. If the 
individual being tested displays a low FEV1 and the 
FEV1% is low, then the presence of an obstructive 
pathology is suspected
1
.  In obstructive lung disease, 
FEF25%-75%, is reduced, likewise PEF, due to an increase 
in airway resistance. 
 
In patients with restrictive lung disease, FEV1and FVC 
are both lower than predicted normal values
8
. Since 
both of these values may equally be affected in 
restrictive disease, the %FEV1 may well be calculated 
to be between 85% and 100% of normal. Hence, 
restrictive pathology is suspected if FEV1 and FVC are 




To distinguish between reversible and irreversible 
obstructive, FEV1 is measured during a post-
bronchodilator test, using a β2–selective 
sympathomimetic agent.  An increase of 10-15% over 
the pre-test FEV1 confirms a reversible obstructive 
disorder. The purpose of the study was to report on the 
proportions of restrictive, obstructive and combined 
types of respiratory diseases in patients referred to 
respiratory units at the Korle Bu Teaching Hospital. 
 
METHOD 
This was a retrospective study using data on patients 
who took LFT’s in the Departments of Physiology and 
Medicine of the Korle Bu Teaching Hospital from 
January 2006 to July 2009. Information gathered 
included VC, FVC, FEV1 and FEV1 ratio, PEF, FEF25% 
- 75%, age, sex, height, and weight. By kind permission 
of the respective departments, a total of 794 subjects’ 
records were available for the purposes of our study, 
out of which a total of 762 subjects’ data were 
analyzed, 394 were from males, and 363 from females. 
Records that were not included in the analysis were 
either incomplete or were not signed by an attending 
specialist. Ages varied from 6 yrs to 87 yrs (median 
age of 35 yrs) whereas weights ranged between 18kg to 
126kg (median weight of 62 kg).  Lung volumes were 
obtained by using a vitalograph, (Vitalograph Alpha by 
Vitalograph Plc, Buckingham, England) which is 
essentially a spirometer consisting of a mouthpiece, 
tubing, and a recording device. The test procedure was 
explained to all subjects and procedure carried out 
following a demonstration of the technique and 
patients’ consent.   
Each subject took a full inspiration and then breathed 
out slowly by blowing air into the disposable 
mouthpiece of the vitalograph, giving the VC.  This 
step was repeated but breathed out quickly with 
maximum effort. This effort gave the FVC curve on the 
vitalograph, from which FEV1, FEV1/FVC ratio, PEF, 
and FEF25% - 75% were derived. Each test was repeated a 
minimum of 3 times and maximum 5 times with 
adequate rest after each manoeuvre for best results. 
Each effort was graded automatically by the spirometer 
on a scale of A to F, and only grades A to C considered 
as acceptable effort. The device was calibrated for 
subjects’ race, height, sex, and age. Subject Body Mass 
Indices (BMI) was obtained by dividing body weight 
(kg) by the square of the subject’s height (m).  . 
 
Statistical analysis: The data were analyzed using Z 
test for two proportions and binary logistic regression 
analyses. Z test was used to analyze the differences in 
the occurrence of the respiratory diseases in our study 
population.  P values less than 0.05 were considered 
significant. Binary logistic regression analysis was 
used to analyze lung conditions in paired BMI groups
2
, 
and also age categories of <35 and ≥35 years (median 
age at time of test in this study).  Odds ratios (OR) >1 
and <1 were considered positive and negative 
associations respectively. The significance or otherwise 
of values of odds ratios was tested by respective values 
of confidence intervals. The Ethical and Protocol 
Review Committee of the University of Ghana Medical 
School approved the protocol for the study. 
 
RESULTS 
Table 1 shows that three hundred and sixty-six (48.0% 
of subjects) were normal (191 males and 175 females), 
194 (25.5%) had obstructive respiratory disease (97 
males and 97 females), 113 (24.8%) had restrictive 
respiratory disease (57 males and 56 females) and 89 
(11.7%) had combined (54 males and 35 females).   
 




No. Of subjects 
(% of Total) 
No. Of subjects 
  Male Female 
Obstructive 194 (25.5) 97 97 
Restrictive 113 (14.8) 57 56 
Combined 89 (11.7) 54 35 
Normal 366 (48.0) 191 175 








Out of 762 subjects who undertook spirometry, 314 
had information recorded on both weights and heights 
from which their BMIs were calculated and data 
analyzed (Table 2).  Odds ratio analyses were 
performed for paired conditions and results presented 
in Table 3. 
 
From Table 2, it would appear that obstructive 
respiratory diseases are as prevalent in obese as it is in 
normal subjects but odds ratio analysis (Table 3) 
however shows that obese patients had a higher risk of 
getting obstructive respiratory disease while the 
underweight were more at risk of getting restrictive 
respiratory disease.  
Table 2 Distribution of Lung condition among BMI 
categories  
 
Table 3 Odds Ratio Analysis of Respiratory Disease in Relation to BMI and Age 
 Obstructive Restrictive Combined 
Paired Categories Odds Ratio (95% confidence interval) 
Obese : Overweight 2.0238 (0.8469 to 4.8362) 1.0618 (0.4407 to 2.5582) 1.3825 (0.4210 to 4.5399) 
Obese : Normal  1.0156 (0.5017 to 2.0557) 0.8533 (0.3871 to 1.8810) 0.5359 (0.2102 to 1.3664) 
Obese : Underweight 3.2786 (0.7092 to 15.1562) 0.6133 (0.2071 to 1.8162) 0.3354 (0.1026 to 1.0969) 
Overweight : Normal 0.5018 (0.2181 to 1.1546) 0.8037 (0.3577 to 1.8058) 0.3877 (0.1361 to 1.1046) 
Overweight : Underweight 1.6200 (0.3290 to 7.9767) 0.5776 (0.1923 to 1.7345) 0.2426 (0.0678 to 0.8677) 
Normal : Underweight 3.2283 (0.7133 to 14.6105) 0.1719 (0.2566 to 2.0132) 0.6259 (0.2207 to 1.7751) 
AGE /years    
≥ 35 : < 35  1.7581 (1.2107 to 2.5531) 0.7118 (0.4709 to 1.0759) 0.9889 (0.6169 to 1.5852) 
 
These differences were, however, not statistically sig-
nificant (OR=0.3354; 95% CI 0.1026 to 1.0969).  Our 
analysis also revealed that, for age below 35 years, 
6.1% of them had obstructive, 5.8% restrictive and 
3.8% combined, while in subjects 35 years and above, 




One of the highlights of our analysis is that, among all 
subjects studied, obstructive lung disease was most 
prevalent (>25%) with equal distribution among the 
sexes. Restrictive and combined respiratory diseases 
follow in that order at nearly 15% and 12% 
respectively with similar sex distribution. 
 
Our study also found nearly half of subjects’ lung 
function to be normal, given that both respiratory units 
handle referred patients and also individuals seeking 
physical examination for purposes including travel, 
employment, and admission to various types of public 
and private institutions. The study suggests that more 
of the respiratory diseases occur in subjects 35 years 
and above, with most of them indicated for obstructive 
lung conditions.  
On the other hand, people below age 35 years had 
about equal preponderance towards restrictive and 
combined respiratory diseases. 
 
We show that there is a significant difference between 
underweight compared to overweight individuals who 
had both obstructive and restrictive conditions. 
Previous studies have also reported associations 
between body weight and various respiratory diseases.   
The weight of evidence suggests an association 
between obesity and obstructive lung disease
13,14,16
, 
except in very severe obesity (BMI>40)
19,20
 where 
restrictive patterns emerge due to the impact of fat on 
respiratory function.  On the other hand, underweight 
may predispose to restrictive or chronic obstructive 




The maneuvers undertaken in these tests are also 
largely dependent on patient’s cooperation and effort, 
and they are normally repeated at least three times to 
ensure reproducibility.   Also, due to the subjective 
nature of the test, vitalograph can only be used on 
children old enough to comprehend and follow 
instructions given and only on patients who are able to 
understand and follow instructions – thus, this test is 
not suitable for patients who are unconscious, or have 
 












6.8 20.6 20.6 51.7 
Normal (18.5-24.9) 19.2 14.0 16.0 50.8 
Overweight (25-
29.0) 
10.7 13.0 5.9 70.2 
Obese (≥30)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    19.5 13.7 8.0 58.6 
 
  




limitation that would interfere with vigorous 
respiratory efforts. 
 
We can conclude from our data gathered from the 
respiratory units of Ghana Medical School and KBTH 
that obstructive respiratory diseases are the most 
prevalent among the subjects, that respiratory diseases 
occurred more in patients who were 35 years and 
above, and that patients below age 35 years are at 
higher risk of combined restrictive and obstructive 
disease. Moreover, the overweight are at the highest 
risk of obstructive lung disease whiles the underweight 
have the highest risk of getting restrictive and 
combined conditions. Respiratory diseases do not 
appear to be sex-biased as the odds of their occurrence 
are the same in both male and female. 
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